EP4 and EP2 receptor subtypes involved in colonic secretion in rat

Basic and Clinical Pharmacology and Toxicology

Volumn 103, Issue 3, 2008, Pages 214-221

  Mosa, Ahmed Soliman ^a   Hansen, Mark Berner ^a,b   Tilotta, Cristina Maria ^a   Bindslev, Niels ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b ASTRAZENECA R AND D   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BUMETANIDE; BUTAPROST; FORSKOLIN; GW 627368X; INDOMETACIN; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E1; PROSTAGLANDIN EP4 RECEPTOR; PROSTAGLANDIN RECEPTOR BLOCKING AGENT; RECEPTOR SUBTYPE; SULPROSTONE; THEOPHYLLINE; DRUG DERIVATIVE; ION; ISOINDOLE DERIVATIVE; N (2 (4 (4,9 DIETHOXY 1 OXO 1,3 DIHYDRO 2H BENZO(F)ISOINDOL 2 YL)PHENYL)ACETYL)BENZENE SULPHONAMIDE; N-(2-(4-(4,9-DIETHOXY-1-OXO-1,3-DIHYDRO-2H-BENZO(F)ISOINDOL-2-YL)PHENYL)ACETYL)BENZENE SULPHONAMIDE; PROSTAGLANDIN E2; PROSTAGLANDIN E2 RECEPTOR, EP4 SUBTYPE; PROSTAGLANDIN EP2 RECEPTOR; SULFONAMIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COLON SECRETION; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SHORT CIRCUIT CURRENT; ANIMAL; COLON; DRUG ANTAGONISM; DRUG POTENTIATION; IN VITRO STUDY; ION TRANSPORT; METABOLISM; PATCH CLAMP; PHYSIOLOGY; SECRETION; WISTAR RAT;

RATTUS;

ALPROSTADIL; ANIMALS; COLON; DINOPROSTONE; ION TRANSPORT; IONS; ISOINDOLES; MALE; PATCH-CLAMP TECHNIQUES; RATS; RATS, WISTAR; RECEPTORS, PROSTAGLANDIN E; SULFONAMIDES;

EID: 49749141408     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2008.00257.x     Document Type: Article

References (49)

1. 2 in circular smooth muscle from dog colon. J Pharmacol Exp Ther 1995 273 : 1008 14.
2. Eberhart CE, DuBois RN. Eicosanoids and the gastrointestinal tract. Gastroenterology 1995 109 : 285 301.
3. Whittle BJR, Vane JR. Prostanoids as regulators of gastrointestinal function. In : Johnson LR (ed.). Physiology of the Gastrointestinal Tract. Raven Press, New York, 1987 143 80.
4. Craven PA, Saito R, DeRubertis FR. Role of local prostaglandin synthesis in the modulation of proliferative activity of rat colonic epithelium. J Clin Invest 1983 72 : 1365 75.
5. Engelmann BE, Bindslev N, Poulsen SS, Hansen MB. Effects of cyclooxygenase and lipoxygenase inhibition on basal- and serotonin-induced ion transport in rat colon. Comp Biochem Physiol C Toxicol Pharmacol 2002 132 : 37 52.
6. Narumiya S, Sugimoto Y, Ushikubi F. Prostanoid receptors: structures, properties, and functions. Physiol Rev 1999 79 : 1193 226.
7. Sugimoto Y, Narumiya S. Prostaglandin E receptor. J Biol Chem 2007 282 : 11613 7.
8. Coleman RA, Smith WL, Narumiya S. International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmacol Rev 1994 46 : 205 29.
9. 2, prostanoid receptors via the phosphatidylinositol 3-kinase and extracellular signal-regulated kinases. J Biol Chem 2003 278 : 12151 6.
10. Fujino H, Regan JW. Prostanoid receptors and phosphatidylinositol 3-kinase: a pathway to cancer? Trends Pharmacol Sci 2003 24 : 335 40.
11. 4 prostanoid receptor signaling. Life Sci 2003 74 : 143 53.
12. 2 activates mitogen-activated protein kinase/Erk pathway signaling and cell proliferation in non-small cell lung cancer cells in an epidermal growth factor receptor-independent manner. Cancer Res 2005 65 : 6275 81.
13. 4 receptor during vertebrate gastrulation. Genes Dev 2006 20 : 77 86.
14. Fujino H, Regan JW. EP(4) prostanoid receptor coupling to a pertussis toxin-sensitive inhibitory G protein. Mol Pharmacol 2006 69 : 5 10.
15. Ding M, Kinoshita Y, Kishi K, Nakata H, Hassan S, Kawanami C et al. Distribution of prostaglandin E receptors in the rat gastrointestinal tract. Prostaglandins 1997 53 : 199 216.
16. Morimoto K, Katsuyama M, Sugimoto Y, Oida H, Tsuboi K, Kishi K et al. Cellular localization of mRNAs for prostaglandin E receptor subtypes in mouse gastrointestinal tract. Am J Physiol 1997 272 : G681 7.
17. Northey A, Denis D, Cirino M, Metters KM, Nantel F. Cellular distribution of prostanoid EP receptors mRNA in the rat gastrointestinal tract. Prostaglandins Other Lipid Mediat 2000 62 : 145 56.
18. Belley A, Chadee K. Prostaglandin E(2) stimulates rat and human colonic mucin exocytosis via the EP(4) receptor. Gastroenterology 1999 117 : 1352 62.
19. 1-selective antagonist. Cancer Sci 2005 96 : 260 4.
20. Hull MA, Ko SC, Hawcroft G. Prostaglandin EP receptors: targets for treatment and prevention of colorectal cancer? Mol Cancer Ther 2004 3 : 1031 9.
21. Halm DR, Halm ST. Prostanoids stimulate K secretion and Cl secretion in guinea pig distal colon via distinct pathways. Am J Physiol Gastrointest Liver Physiol 2001 281 : G984 96.
22. 4 receptor antagonist. Br J Pharmacol 2006 148 : 326 39.
23. Puntheeranurak S, Schreiber R, Spitzner M, Ousingsawat J, Krishnamra N, Kunzelmann K. Control of ion transport in mouse proximal and distal colon by prolactin. Cell Physiol Biochem 2007 19 : 77 88.
24. Allen A, Flemstrom G. Gastroduodenal mucus bicarbonate barrier: protection against acid and pepsin. Am J Physiol Cell Physiol 2005 288 : C1 19.
25. McKinney M, Anderson DJ, Vella-Rountree L, Connolly T, Miller JH. Pharmacological profiles for rat cortical M1 and M2 muscarinic receptors using selective antagonists: comparison with N1E-115 muscarinic receptors. J Pharmacol Exp Ther 1991 257 : 1121 9.
26. Craig DA. The Cheng-Prusoff relationship: something lost in the translation. Trends Pharmacol Sci 1993 14 : 89 91.
27. Kim SJ, Nam JH, Woo JE, Kim SJ, Rhee PL. Ca(2+) influx through the basolateral- and luminal membranes of colonic epithelium in neonatal rats. Pflugers Arch 2004 447 : 408 15.
28. + secretion across distal colonic epithelium. Am J Physiol Cell Physiol 2006 291 : C636 48.
29. Schultheiss G, Horger S, Diener M. The bumetanide-resistant part of forskolin-induced anion secretion in rat colon. Acta Physiol Scand 1998 164 : 219 28.
30. Suda M, Tanaka K, Natsui K, Usui T, Tanaka I, Fukushima M et al. Prostaglandin E receptor subtypes in mouse osteoblastic cell line. Endocrinology 1996 137 : 1698 705.
31. Asano TK, McLeod RS. Nonsteroidal anti-inflammatory drugs and aspirin for the prevention of colorectal adenomas and cancer: a systematic review. Dis Colon Rectum 2004 47 : 665 73.
32. 2 production. Br J Pharmacol 2005 144 : 338 48.
33. Fulton AM, Ma X, Kundu N. Targeting prostaglandin E EP receptors to inhibit metastasis. Cancer Res 2006 66 : 9794 97.
34. Mauritz I, Westermayer S, Marian B, Erlach N, Grusch M, Holzmann K. Prostaglandin E(2) stimulates progression-related gene expression in early colorectal adenoma cells. Br J Cancer 2006 94 : 1718 25.
35. 4 antagonism inhibits breast cancer metastasis. Cancer Res 2006 66 : 2923 27.
36. Liu X, Lazenby AJ, Siegal GP. Signal transduction cross-talk during colorectal tumorigenesis. Adv Anat Pathol 2006 13 : 270 74.
37. 2 promotes angiogenesis in colorectal cancer. J Exp Med 2006 203 : 941 51.
38. Wang D, DuBois RN. Prostaglandins and cancer. Gut 2006 55 : 115 22.
39. Wang D, Wang H, Guo Y, Ning W, Katkuri S, Wahli W et al. Crosstalk between peroxisome proliferator-activated receptor (delta) and VEGF stimulates cancer progression. Proc Natl Acad Sci USA 2006 103 : 19069 74.
40. Wang D, DuBois RN. Inflammatory mediators and nuclear receptor signaling in colorectal cancer. Cell Cycle 2007 6 : 682 5.
41. Mutoh M, Watanabe K, Kitamura T, Shoji Y, Takahashi M, Kawamori T et al. Involvement of prostaglandin E receptor subtype EP(4) in colon carcinogenesis. Cancer Res 2002 62 : 28 32.
42. 4 receptor expression in colorectal cancer progression promotes cell growth and anchorage independence. Cancer Res 2006 66 : 3106 13.
43. 3 during colon cancer development. Gut 2004 53 : 1151 8.
44. 2 receptor subtype with rat dextran sodium sulphate colitis: colitis suppression by a selective agonist, ONO-AE1-329. Scand J Immunol 2002 56 : 66 75.
45. Sasaki S, Hirata I, Maemura K, Hamamoto N, Murano M, Toshina K et al. Prostaglandin E2 inhibits lesion formation in dextran sodium sulphate-induced colitis in rats and reduces the levels of mucosal inflammatory cytokines. Scand J Immunol 2000 51 : 23 8.
46. 4 suppresses colitis, mucosal damage and CD4 cell activation in the gut. J Clin Invest 2002 109 : 883 93.
47. 4 agonist through enhancement of epithelium survival and regeneration. J Pharmacol Exp Ther 2006 230 : 22 8
48. Takafuji V, Lublin D, Lynch K, Roche JK. Mucosal prostanoid receptors and synthesis in familial adenomatous polyposis. Histochem Cell Biol 2006 116 : 171 8.
49. 4 antagonists on intestinal tumorigenesis in adenomatous polyposis coli gene knockout mice. Cancer Sci 2003 94 : 618 21.